New RSV vaccine called Arexy approved for people aged 60 and older
Health Canada has authorized the first RSV vaccine for people aged 60 and older.
Doctors have been calling for the vaccine for this group, which is at a higher risk of becoming severely ill from the virus.
Drugmaker GSK says during clinical trials, the drug was 82 percent effective at lowering respiratory tract disease caused by RSV.
In Canada, RSV season usually starts in the fall, and ends in the spring.

More Charges Laid in Smithville Murder
Yielding to Winter Blahs Challenged
Speeding Driver Asks for Warning
Niagara Chair Touches on Budget
Man Charged with Indecent Act
2 Drivers Arrested in RIDE Checks
By Comparison, Niagara Great for Real Estate